Alterity Therapeutics (ATHE) Stock Chart & Stock Price History $4.63 +0.04 (+0.87%) Closing price 04:00 PM EasternExtended Trading$4.74 +0.11 (+2.38%) As of 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alterity Therapeutics Stock Price Performance The Alterity Therapeutics (ATHE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 130.61%, with a year-to-date return of 39.88%. In the past month, the stock has increased 5.23%, reflecting recent market activity. As of the latest close, Alterity Therapeutics traded at $4.59 with a market cap of $40.71 million and volume of 658,357 shares. Receive ATHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+18.41%1 Month Performance+5.23%3 Month Performance+44.24%Year-To-Date Performance+39.88%1 Year Performance+130.61% ATHE Stock Chart for Monday, July, 14, 2025 ATHE Chart by TradingView Alterity Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/11/2025$3.93$4.59+16.79%$5.51$4.50658,357 shs$40.71 million07/10/2025$3.91$3.93+0.51%$3.99$3.8636,319 shs$34.85 million07/09/2025$4.11$3.91-4.87%$4.00$3.8520,903 shs$34.68 million07/08/2025$3.87$4.11+6.20%$4.20$3.8620,740 shs$36.46 million07/07/2025$4.04$3.87-4.09%$4.03$3.7717,533 shs$34.32 million07/04/2025$4.04$4.04$4.15$3.8811,274 shs$35.79 million07/03/2025$4.04$4.04-0.12%$4.15$3.8811,274 shs$35.85 million07/02/2025$4.09$4.04-1.10%$4.25$3.919,509 shs$35.84 million07/01/2025$4.09$4.09-0.12%$4.17$3.9021,657 shs$36.23 million06/30/2025$3.93$4.09+4.07%$4.23$3.959,929 shs$36.28 million Get the Latest News and Ratings for ATHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/27/2025$3.92$3.93+0.26%$4.11$3.8766,743 shs$34.86 million06/26/2025$3.84$3.92+2.08%$4.15$3.8190,255 shs$34.77 million06/25/2025$4.43$3.84-13.22%$4.35$3.81137,277 shs$34.06 million06/24/2025$4.37$4.43+1.26%$4.63$4.3512,628 shs$39.24 million06/23/2025$4.23$4.37+3.31%$4.54$4.3330,405 shs$38.76 million06/20/2025$4.34$4.23-2.53%$4.37$4.2019,818 shs$37.52 million06/19/2025$4.34$4.34$4.46$4.3011,130 shs$38.48 million06/18/2025$4.33$4.34+0.23%$4.46$4.3011,130 shs$38.50 million06/17/2025$4.41$4.33-1.81%$4.50$4.334,070 shs$38.39 million06/16/2025$4.40$4.41+0.23%$4.49$4.3215,127 shs$39.10 million06/13/2025$4.59$4.40-4.14%$4.63$4.3022,706 shs$39.02 million Related Companies THTX Stock Chart BDTX Stock Chart ALTS Stock Chart LYEL Stock Chart IKT Stock Chart SKYE Stock Chart GALT Stock Chart GLSI Stock Chart RAPT Stock Chart NMRA Stock Chart Receive ATHE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Alterity Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ATHE) was last updated on 7/14/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alterity Therapeutics Limited - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Alterity Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ATHE Stock Alerts